BiomX Raises $32 Million in Series B Financing
BiomX Ltd., a microbiome company developing customized phage therapies, announced on 2/20/19 the closing of a $32 million series B equity financing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,